Olig1 is expressed in human oligodendrocytes during maturation and regeneration

GLIA

Volumn 59, Issue 6, 2011, Pages 914-926

  Othman, Ahmad ^a   Frim, David M ^b   Polak, Paul ^a   Vujicic, Snezana ^a   Arnason, Barry G W ^b   Boullerne, Anne I ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Nkx2.2; Olig2; OPC; PPAR ; Sox10

Indexed keywords

CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; MESSENGER RNA; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 1; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL ISOLATION; CELL MATURATION; CELL REGENERATION; CHILD; CLINICAL ARTICLE; EPILEPSY; FEMALE; HUMAN; HUMAN CELL; MALE; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SCHOOL CHILD; STEM CELL;

ADOLESCENT; ANIMALS; ANIMALS, NEWBORN; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL MEMBRANE; CELLS, CULTURED; CHILD; EPILEPSY; FEMALE; HUMANS; MALE; MICE; NERVE REGENERATION; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; YOUNG ADULT;

EID: 79954617268     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21163     Document Type: Article

References (50)

1. Allamargot C, Gardinier MV. 2007. Alternative isoforms of myelin/oligodendrocyte glycoprotein with variable cytoplasmic domains are expressed in human brain. J Neurochem 101: 298-312.
2. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD. 2004. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 306: 2111-2115.
3. Blain M, Miron VE, Lambert C, Darlington PJ, Cui Q-L, Saikali P, Yong VW, Antel JP. 2010. Isolation and Culture of Primary Human CNS Neural Cells. In: Doering LC, editor. Protocols for Neural Cell Culture, fourth edition. Humana Press. pp 87-104.
4. Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, Nave KA, Birchmeier C, Wegner M. 2001. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15: 66-78.
5. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346: 165-173.
6. Copray S, Balasubramaniyan V, Levenga J, de Bruijn J, Liem R, Boddeke E. 2006. Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes. Stem Cells 24: 1001-1010.
7. Delarasse C, Daubas P, Mars LT, Vizler C, Litzenburger T, Iglesias A, Bauer J, Della Gaspera B, Schubart A, Decker L, Dimitri D, Roussel G, Dierich A, Amor S, Dautigny A, Liblau R, Pham-Dinh D. 2003. Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest 112: 544-553.
8. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M. 2002. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35: 283-290.
9. Dugas JC, Tai YC, Speed TP, Ngai J, Barres BA. 2006. Functional genomic analysis of oligodendrocyte differentiation. J Neurosci 26: 10967-10983.
10. Fancy SP, Zhao C, Franklin RJ. 2004. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci 27: 247-54.
11. Gokhan S, Marin-Husstege M, Yung SY, Fontanez D, Casaccia-Bonnefil P, Mehler MF. 2005. Combinatorial profiles of oligodendrocyte-selective classes of transcriptional regulators differentially modulate myelin basic protein gene expression. J Neurosci 25: 8311-8321.
12. Granneman J, Skoff R, Yang X. 1998. Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes. J Neurosci Res 51: 563-573.
13. Johns TG, Bernard CC. 1999. The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem 72: 1-9.
14. Kainu T, Wikström AC, Gustafsson JA, Pelto-Huikko M. 1994. Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 5: 2481-2485.
15. Kitada M, Rowitch DH. 2006. Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia 54: 35-46.
16. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M. 1998. Sox10, a novel transcriptional modulator in glial cells. J Neurosci 18: 237-250.
17. Kuhlmann T, Miron V, Cuo Q, Wegner C, Antel J, Brück W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131: 1749-1758.
18. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366-374.
19. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H, Gonzalez FJ. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022.
20. Li H, Lu Y, Smith HK, Richardson WD. 2007. Olig1 and Sox10 interact synergistically to drive myelin basic protein transcription in oligodendrocytes. J Neurosci 27: 14375-14382.
21. Ligon KL, Fancy SP, Franklin RJ, Rowitch DH. 2006. Olig gene function in CNS development and disease. Glia 54: 1-10.
22. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH. 2000. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25: 317-329.
23. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. 2002. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109: 75-86.
24. Maire CL, Buchet D, Kerninon C, Deboux C, Baron-Van Evercooren A, Nait-Oumesmar B. 2009. Directing human neural stem/precursor cells into oligodendrocytes by overexpression of Olig2 transcription factor. J Neurosci Res 87: 3438-3446.
25. Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K. 2001. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 358: 298-300.
26. Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Höglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. 2007. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci USA 104: 4694-4699.
27. Nave KA, Trapp BD. 2008. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31: 535-561.
28. Nicolay DJ, Doucette JR, Nazarali AJ. 2007. Transcriptional control of oligodendrogenesis. Glia 55: 1287-1299.
29. Paintlia MK, Paintlia AS, Khan M, Singh I, Singh AK. 2008. Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem 105: 956-970.
30. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129: 3165-3172.
31. Pedraza CE, Monk R, Lei J, Hao Q, Macklin WB. 2008. Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors. Glia 56: 1339-1352.
32. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ. 2000. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol 20: 5119-5128.
33. Polak PE, Kalinin S, Dello Russo C, Gavrilyuk V, Sharp A, Peters JM, Richardson J, Willson TM, Weinberg G, Feinstein DL. 2005. Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol 168: 65-75.
34. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. 1993. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33: 137-151.
35. Qi Y, Cai J, Wu Y, Wu R, Lee J, Fu H, Rao M, Sussel L, Rubenstein J, Qiu M. 2001. Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development 128: 2723-2733.
36. Saluja I, Granneman JG, Skoff RP. 2001. PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. Glia 33: 191-204.
37. Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J. 1998. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121: 2221-2228.
38. Sim FJ, Lang JK, Waldau B, Roy NS, Schwartz TE, Pilcher WH, Chandross KJ, Natesan S, Merrill JE, Goldman SA. 2006. Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann Neurol 59: 763-779.
39. Sim FJ, Lang JK, Ali TA, Roy NS, Vates GE, Pilcher WH, Goldman SA. 2008. Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation. Glia 56: 954-962.
40. Simonini MV, Polak PE, Boullerne AI, Peters JM, Richardson JC, Feinstein DL. 2010. Regulation of oligodendrocyte progenitor cell maturation by PPARdelta: effects on bone morphogenetic proteins. ASN Neuro 2(1): AN20090033.
41. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, Schachner M, Bartsch U, Wegner M. 2002. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev 16: 165-170.
42. Szuchet S. 1995. The morphology and ultrastructure of oligodendrocytes and their functional implications. In: Kettenmann K, Ransom BR, editors. Neuroglia. New York: Oxford University Press. pp. 23-43.
43. Wang SZ, Dulin J, Wu H, Hurlock E, Lee SE, Jansson K, Lu QR. 2006. An oligodendrocyte-specific zinc-finger transcription regulator cooperates with Olig2 to promote oligodendrocyte differentiation. Development 133: 3389-3398.
44. Watanabe M, Hadzic T, Nishiyama A. 2004. Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia 46: 311-322.
45. Wegner M. 2008. A matter of identity: transcriptional control in oligodendrocytes. J Mol Neurosci 35: 3-12.
46. Woods JW, Tanen M, Figueroa DJ, Biswas C, Zycband E, Moller DE, Austin CP, Berger JP. 2003. Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons. Brain Res 975: 10-21.
47. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. JNeurosci 18: 601-609.
48. Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR. 2005. Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25: 1354-1365.
49. Zhou Q, Wang S, Anderson DJ. 2000. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 25: 331-343.
50. Zhou Q, Choi G, Anderson DJ. 2001. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 31: 791-807.